Demographic data of the patients with PsA
| PsA with surgeries | PsA without surgeries | p Value | |
|---|---|---|---|
| Number of patients | 130 (48.33%) | 139 (51.67%) | − |
| Males/females | 84 (64.62%)/46 (35.38%) | 80 (57.55%)/58 (41.73%) | 0.26 |
| Mean age (years)±SD | 54.13±11.03 | 53.73±12.81 | 0.78 |
| Mean HAQ 3 score±SD | 0.95±0.82 | 0.59±0.68 | <0.001 |
| Number of patients currently on | |||
| TNF-α blockers±DMARDs | 64 (49.23%) | 55 (39.56%) | 0.11 |
| DMARDs | 55 (42.30%) | 66 (47.48%) | 0.39 |
| None | 11 (8.46%) | 18 (12.94%) | 0.24 |
†Mann-Whitney U test.
DMARDs, disease-modifying antirheumatic drugs; PsA, psoriatic arthritis; TNF, tumour necrosis factor.